Palliative care needs and outcomes for dementia patients
痴呆症患者的姑息治疗需求和结果
基本信息
- 批准号:10468328
- 负责人:
- 金额:$ 72.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-30 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:Advance Care PlanningAdvance DirectivesAgingAlzheimer&aposs DiseaseAmericanAreaAudiotapeAutopsyBiopsyBloodCaliforniaCaringCause of DeathCerebrospinal FluidCessation of lifeClinicalCognitiveCommunitiesConsentConsultDecision MakingDementiaDiseaseDistressDocumentationEmergency SituationEnrollmentEthnic OriginEvaluationEventFamilyFecesFutureGoalsHealthcareHispanicHobbiesHomeHome visitationHospitalizationHourInternationalInterventionJudgmentLatinoLength of StayLifeMeasuresMediator of activation proteinMedicalMemoryMethodsMonitorNursesNursing ResearchOutcomePainPalliative CareParticipantPatientsPatternPerformancePersonsPhysiciansPopulationPrevalencePrivatizationProblem SolvingPublic HealthQuality of lifeRandomizedRandomized Clinical TrialsResearchResearch TrainingResortResourcesSelf CareSisterSkinStandardizationSymptomsTelephoneTerminal DiseaseTestingTimeTreatment outcomeVisitVoiceWorkWorld Health Organizationagedaging populationcare systemscohortdesignend of lifeexperiencefunctional statusimprovedindividual patientmultidisciplinaryneuropsychiatric symptomneuropsychiatrypain symptompalliatepalliativepatient orientedphysical symptompreferencepsychological symptompublic health prioritiesrecruitresidenceresidential care facilitysymptom managementtreatment armtreatment as usualusual care arm
项目摘要
The number of people living with dementia worldwide, estimated at 35.6 million in 2010, is set to nearly double
every 20 years, reaching 65.7 million in 2030, and 115.4 million in 2050.
The World Health Organization has
declared dementia a public health crisis and issued a call for global nations to make dementia an international
public health priority. Dementia is a terminal disease and was the sixth leading cause of death in the US in
2014. Little is known about the everyday lived experiences and suffering endured over time by patients in the
early stages of dementia as most research focuses on patient experiences in the later stages of dementia and
often on those who are already institutionalized. However, patients early in the dementia trajectory are beset
with distressing symptoms. Three out of four Persons With Dementia (PWD) live in the community (e.g.,
private residences or non-nursing home residential care facilities). Proactive, patient-centered palliative
interventions will better prepare patients and families for the challenges of living with dementia in the
community. Implementing early palliative care will facilitate ongoing assessment and management of the
distressing symptoms experienced by PWD from very early in the illness trajectory and result in better
symptom management, quality of life and timely advance care planning. The Stanford Alzheimer's Disease
Research Center (ADRC) was founded in 2015 and we have enrolled a large (and growing) panel of
participants whom we follow longitudinally until death. Recognizing that the primary components of palliative
care include symptom assessment and management, advance care planning completion and provision of
support with end-of-life decision-making, we have designed, refined, and piloted an intervention to be used in
the proposed Randomized Clinical Trial (RCT). We will recruit 200 Stanford ADRC participants and randomize
100 each to usual care (UC) or usual care plus an early palliative care intervention (EPC) to be delivered by a
nurse over a twelve-month period. The EPC will include one nurse-led palliative consult in a two-hour house
call and followed by 11 monthly 30-minute phone assessment plus usual care. The specific aims of the RCT
are (i) To determine whether EPC will lead to lower symptom burden, higher quality of life, lesser resource use
(e.g. hospital admissions and days, emergency visits) & greater patient activation; (ii) To use all the baseline
standardized evaluation measures established by the National Alzheimer's Coordinating Center (NACC) that
are routinely collected on our ADRC participants to identify moderators and mediators of treatment outcome
and (iii) To use mixed-methods to analyze the audiotapes of the encounters between the research nurse and
the patient during the twelve intervention sessions and to assess whether the information that is provided to
participants differs by patient ethnicity and cognitive levels. This RCT provides a very rare opportunity to
monitor the palliative needs over time of community-dwelling ADRC participants and has great potential to
inform future studies by our sister ADRCs on the palliative needs of persons with dementia.
据估计,2010年全球痴呆症患者人数为3560万,
每20年,2030年达到6570万,2050年达到1.154亿。
世界卫生组织
宣布痴呆症是一场公共卫生危机,并呼吁全球各国将痴呆症作为一个国际问题,
公共卫生优先。痴呆症是一种晚期疾病,是年美国第六大死亡原因。
2014.关于在美国的病人的日常生活经历和随着时间的推移所忍受的痛苦,人们知之甚少。
痴呆症的早期阶段,因为大多数研究都集中在痴呆症后期阶段的患者经历上,
通常是那些已经被制度化的人。然而,痴呆症早期的患者
出现了令人痛苦的症状四分之三的痴呆症患者(PWD)生活在社区(例如,
私人住宅或非疗养院住宿护理设施)。主动、以患者为中心的姑息治疗
干预措施将使患者和家庭更好地为应对痴呆症生活的挑战做好准备
社区实施早期姑息治疗将有助于持续评估和管理
PWD从疾病轨迹的早期经历的痛苦症状,并导致更好的
症状管理、生活质量和及时的提前护理计划。斯坦福大学老年痴呆症
研究中心(ADRC)成立于2015年,我们已经招募了一个大型(和不断增长的)面板,
我们会纵向跟踪这些参与者直到他们死亡。认识到姑息疗法的主要成分
护理包括症状评估和管理,提前完成护理计划并提供
为了支持生命终结决策,我们设计、完善并试行了一种干预措施,
随机临床试验(RCT)。我们将招募200名斯坦福大学的ADRC参与者,
常规护理(UC)或常规护理加早期姑息治疗干预(EPC)各100例,由
护士在12个月内。EPC将包括一个护士主导的姑息性咨询在两小时的房子
电话,然后是11个月30分钟的电话评估加上日常护理。RCT的具体目标
(i)确定EPC是否会导致更低的症状负担、更高的生活质量、更少的资源使用
(e.g.(二)使用所有的基线,
国家阿尔茨海默氏症协调中心(NACC)制定的标准化评估措施,
对我们的ADRC参与者进行常规收集,以确定治疗结果的调节剂和介导剂
及(iii)使用混合方法分析研究护士与
在12个干预会话期间对患者进行评估,并评估提供给
参与者因患者种族和认知水平而异。本RCT提供了一个非常难得的机会,
随着时间的推移,监测社区居住的ADRC参与者的缓解需求,并具有很大的潜力,
为我们的姐妹ADRC未来关于痴呆症患者姑息治疗需求的研究提供信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VYJEYANTHI S PERIYAKOIL其他文献
VYJEYANTHI S PERIYAKOIL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VYJEYANTHI S PERIYAKOIL', 18)}}的其他基金
Longevity, Equity, and Aging Research Network (L.E.A.R.N.) Consortium Leadership & Administrative Core
长寿、公平和老龄化研究网络 (L.E.A.R.N.) 联盟领导
- 批准号:
10730179 - 财政年份:2018
- 资助金额:
$ 72.79万 - 项目类别:
Longevity, Equity, and Aging Research Network (L.E.A.R.N.) Consortium
长寿、公平和老龄化研究网络 (L.E.A.R.N.) 联盟
- 批准号:
10730178 - 财政年份:2018
- 资助金额:
$ 72.79万 - 项目类别:
Stanford Aging & Ethnogeriatrics Transdisciplinary Collaborative Center (SAGE)
斯坦福老龄化
- 批准号:
10450103 - 财政年份:2018
- 资助金额:
$ 72.79万 - 项目类别:
Palliative care needs and outcomes for dementia patients
痴呆症患者的姑息治疗需求和结果
- 批准号:
10673767 - 财政年份:2018
- 资助金额:
$ 72.79万 - 项目类别:
Palliative care needs and outcomes for dementia patients
痴呆症患者的姑息治疗需求和结果
- 批准号:
9791156 - 财政年份:2018
- 资助金额:
$ 72.79万 - 项目类别:
Palliative care needs and outcomes for dementia patients
痴呆症患者的姑息治疗需求和结果
- 批准号:
9984221 - 财政年份:2018
- 资助金额:
$ 72.79万 - 项目类别:
Stanford Aging & Ethnogeriatrics Transdisciplinary Collaborative Center (SAGE)
斯坦福老龄化
- 批准号:
10658924 - 财政年份:2018
- 资助金额:
$ 72.79万 - 项目类别:
相似海外基金
Improving Ethical Care for Patients who are Incapacitated with No Evident Advance Directives or Surrogates (INEADS)
改善对没有明显预先指示或代理人的无行为能力患者的道德护理 (INEADS)
- 批准号:
10248503 - 财政年份:2020
- 资助金额:
$ 72.79万 - 项目类别:
Improving Ethical Care for Patients who are Incapacitated with No Evident Advance Directives or Surrogates (INEADS)
改善对没有明显预先指示或代理人的无行为能力患者的道德护理 (INEADS)
- 批准号:
10038963 - 财政年份:2020
- 资助金额:
$ 72.79万 - 项目类别:
Investigation of essential components of advance directives completion among Japanese elders and development of the individual support program
日本老年人完成预先指示的基本组成部分的调查以及个人支持计划的制定
- 批准号:
18K10557 - 财政年份:2018
- 资助金额:
$ 72.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Research on the diffusion of Advance directives of ALS (Amyotrophic lateral sclerosis) patients by designation as Proxy decision maker
通过指定代理决策者对 ALS(肌萎缩侧索硬化症)患者预先指示的传播进行研究
- 批准号:
16K08858 - 财政年份:2016
- 资助金额:
$ 72.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A Trial of Expanded Choice Sets in Advance Directives for Hemodialysis Patients
血液透析患者预先医疗指示中扩大选择集的试验
- 批准号:
8982352 - 财政年份:2016
- 资助金额:
$ 72.79万 - 项目类别:
Cohort Study of Advance Directives and End of Life Care
预先指示和临终关怀的队列研究
- 批准号:
15K08549 - 财政年份:2015
- 资助金额:
$ 72.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Research on the state of psychiatric care that respects self-determination via psychiatric advance directives
通过精神病预先指示尊重自我决定的精神病护理状况的研究
- 批准号:
15K15259 - 财政年份:2015
- 资助金额:
$ 72.79万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Prospective cohort study for the change in advance directives among community-dwelling older adults
社区老年人预先指示变化的前瞻性队列研究
- 批准号:
15K19151 - 财政年份:2015
- 资助金额:
$ 72.79万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
New advance directives as a communication tool between elders and their family
新的预先指示作为长者与其家人之间的沟通工具
- 批准号:
25862130 - 财政年份:2013
- 资助金额:
$ 72.79万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
The development of the Japanese in the end-of-life care "advance directives"and Study of the role of social worker
日本临终关怀“预先指示”的发展及社会工作者的角色研究
- 批准号:
24730479 - 财政年份:2012
- 资助金额:
$ 72.79万 - 项目类别:
Grant-in-Aid for Young Scientists (B)














{{item.name}}会员




